Online Program to Reduce Depression in MS

NACompletedINTERVENTIONAL
Enrollment

279

Participants

Timeline

Start Date

February 15, 2017

Primary Completion Date

January 30, 2021

Study Completion Date

May 1, 2021

Conditions
Multiple Sclerosis
Interventions
BEHAVIORAL

Deprexis, DeprexisPlus

Online program Deprexis, either as a stand-alone internet-based intervention (Deprexis) or with added standardized email support by a clinical psychologist (DeprexisPlus). In this trial, we will use a Version of Deprexis that has been adapted to MS-specific needs.

Trial Locations (5)

10117

Charité University, Berlin

16801

Penn State University, State College

20246

Universitätsklinikum Hamburg-Eppendorf, Hamburg

66103

University of Missouri, Kansas City, Kansas City

90048

Cedars-Sinai Medical Center, Los Angeles

All Listed Sponsors
collaborator

National Multiple Sclerosis Society

OTHER

collaborator

Universitätsklinikum Hamburg-Eppendorf

OTHER

collaborator

Cedars-Sinai Medical Center

OTHER

collaborator

University of Missouri, Kansas City

OTHER

collaborator

Penn State University

OTHER

collaborator

King's College London

OTHER

collaborator

University Medical Center Goettingen

OTHER

collaborator

NeuroCure Clinical Research Center, Charite, Berlin

OTHER

lead

Charite University, Berlin, Germany

OTHER

NCT02740361 - Online Program to Reduce Depression in MS | Biotech Hunter | Biotech Hunter